Literature DB >> 27377615

Expression and Secretion of Endostar Protein by Escherichia Coli: Optimization of Culture Conditions Using the Response Surface Methodology.

Abbas Mohajeri1,2, Jalal Abdolalizadeh3, Younes Pilehvar-Soltanahmadi1,4, Farhad Kiafar2, Nosratollah Zarghami5,6,7.   

Abstract

Endostar as a specific drug in treatment of the nonsmall cell lung cancer is produced using Escherichia coli expression system. Plackett-Burman design (PBD) and response surface methodology (RSM) are statistical tools for experimental design and optimization of biotechnological processes. This investigation aimed to predict and develop the optimal culture condition and its components for expression and secretion of endostar into the culture medium of E. coli. The synthetic endostar coding sequence was fused with PhoA signal peptide. The nine factors involved in the production of recombinant protein-postinduction temperature, cell density, rotation speed, postinduction time, concentration of glycerol, IPTG, peptone, glycine, and triton X-100-were evaluated using PBD. Four significant factors were selected based on PBD results for optimizing culture condition using RSM. Endostar was purified using cation exchange chromatography and size exclusion chromatography. The maximum level of endostar was obtained under the following condition: 13.57-h postinduction time, 0.76 % glycine, 0.7 % triton X-100, and 4.87 % glycerol. The predicted levels of endostar was significantly correlated with experimental levels (R 2 = 0.982, P = 0.00). The obtained results indicated that PBD and RSM are effective tools for optimization of culture condition and its components for endostar production in E. coli. The most important factors in the enhancement of the protein production are glycerol, glycine, and postinduction time.

Entities:  

Keywords:  Angiogenesis inhibitors; Endostar; Escherichia coli; Lung cancer

Mesh:

Substances:

Year:  2016        PMID: 27377615     DOI: 10.1007/s12033-016-9963-9

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  25 in total

1.  High level expression of human endostatin in Pichia pastoris using a synthetic gene construct.

Authors:  Zhijian Su; Xiaoping Wu; Ya Feng; Changcai Ding; Yechen Xiao; Lu Cai; Wenke Feng; Xiaokun Li
Journal:  Appl Microbiol Biotechnol       Date:  2006-11-18       Impact factor: 4.813

2.  The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures.

Authors:  Andrea Vera; Nuria González-Montalbán; Anna Arís; Antonio Villaverde
Journal:  Biotechnol Bioeng       Date:  2007-04-15       Impact factor: 4.530

3.  Cloning and Expression of Recombinant Human Endostatin in Periplasm of Escherichia coli Expression System.

Authors:  Abbas Mohajeri; Yones Pilehvar-Soltanahmadi; Mohammad Pourhassan-Moghaddam; Jalal Abdolalizadeh; Pouran Karimi; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2016-06-30

4.  Cloning, expression, purification, and characterization of the membrane protein UncI from Escherichia coli.

Authors:  Claudia Hartmann; Andreas Engel
Journal:  Protein Expr Purif       Date:  2011-05-30       Impact factor: 1.650

5.  Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.

Authors:  Wanlu Cao; Haixin Li; Juan Zhang; Daojuan Li; Desmond Omane Acheampong; Zhiguo Chen; Min Wang
Journal:  Protein Expr Purif       Date:  2013-05-13       Impact factor: 1.650

6.  Generation of New M2e-HA2 Fusion Chimeric Peptide to Development of a Recombinant Fusion Protein Vaccine.

Authors:  Ali Ameghi; Behzad Baradaran; Khosrow Aghaiypour; Abolfazl Barzegar; Yones Pilehvar-Soltanahmadi; Masood Moghadampour; Morteza Taghizadeh; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 7.  Secretory and extracellular production of recombinant proteins using Escherichia coli.

Authors:  J H Choi; S Y Lee
Journal:  Appl Microbiol Biotechnol       Date:  2004-02-14       Impact factor: 4.813

8.  Optimization of a single-chain antibody fragment overexpression in Escherichia coli using response surface methodology.

Authors:  V Akbari; H Mir Mohammad Sadeghi; A Jafarian-Dehkordi; C Perry Chou; D Abedi
Journal:  Res Pharm Sci       Date:  2015 Jan-Feb

9.  Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor.

Authors:  Ariane Leites Larentis; Júlia Fabiana Monteiro Quintal Nicolau; Gabriela dos Santos Esteves; Daniel Tait Vareschini; Fernanda Vicente Ribeiro de Almeida; Mitermayer Galvão dos Reis; Ricardo Galler; Marco Alberto Medeiros
Journal:  BMC Res Notes       Date:  2014-09-25

10.  Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.

Authors:  Xiaoming Xu; Wei Mao; Qian Chen; Qin Zhuang; Lihui Wang; Jin Dai; Haibing Wang; Zhaoquan Huang
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

View more
  2 in total

1.  Optimization of physical conditions for the production of thermostable T1 lipase in Pichia guilliermondii strain SO using response surface methodology.

Authors:  Mary Ladidi Abu; Hisham Mohd Nooh; Siti Nurbaya Oslan; Abu Bakar Salleh
Journal:  BMC Biotechnol       Date:  2017-11-10       Impact factor: 2.563

Review 2.  An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors:  Hajie Lotfi; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Bioimpacts       Date:  2017-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.